Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04931004 · ClinicalTrials.gov registry record · Early Phase 1
Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
A Early Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 34
- Enrollment target
NCT04931004 is a Early Phase 1 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 34 participants.
The verdict
NCT04931004, a Early Phase 1 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Prospective, cross-sectional study evaluating the effect of commercially available mouthwashes on expelled/exhaled SARS-CoV-2 viral load using face mask sampling.
Interventions
- DRUG Mouthwash Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2022-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04931004
The ClinicalTrials.gov registry entry for NCT04931004 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mouthwash Product is the first listed.
NCT04931004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04931004 about?
NCT04931004 is a clinical study titled "Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection". Prospective, cross-sectional study evaluating the effect of commercially available mouthwashes on expelled/exhaled SARS-CoV-2 viral load using face mask sampling.
What is the current status of trial NCT04931004?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 34 participants. The study started on 2021-07-21. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04931004?
The interventions under investigation include: Mouthwash Product (DRUG).
Who is sponsoring clinical trial NCT04931004?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.